New CRO for CytoDyn

New CRO for CytoDyn, at least for the Phase 3 Monotherapy trial, will be PPD. That's according to NP on the December 6th proactive video, 2:40 mark. https://www.youtube.com/watch?v=3mJHMlitY1k

Who is PPD?

PPD was founded by Fred Eshelman in 1985 as a one person consulting firm to its position today as a leading global contract research organization (CRO), PPD’s history is shaped by its commitment to consistent quality and execution, exceptional customer aligned service and continuous innovation to speed the overall execution of clinical trials. With offices in 47 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life changing therapies to improve health and they dedicatedly provides clinical research for pharmaceutical, biotechnology, medical device, academic and government organizations services including drug development, laboratory and lifecycle management and that is reason PPD has counted one of the largest organization in the world.

Key information :

Founder : Fredric N Eshelman
CEO : David Simmons
Headquarters : Wilmington, North Carolina, United States
Services : Contract Clinical Research for pharmaceutical, biotechnology, medical Device, academic, Drug development, laboratory, and lifecycle Management.
Revenue : $4.031 Billion USD
Number of Employees : 24,000 (2020)
Website : https://www.ppd.com/